| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 4 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 | |
| #3 | China | 2 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | Israel | 1 |
| # | Industry | |
|---|---|---|
| #1 | Measurement | |
| #2 | Computer technology | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Bioinformatics | |
| #3 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sorek Rachel | 9 |
| #2 | Safer Pennina | 7 |
| #3 | Reiner-Benaim Anat | 6 |
| #4 | Jakobi Keren | 5 |
| #5 | Jakob Keren | 3 |
| #6 | Jakobi-Brook Keren | 3 |
| #7 | Cohen Irun R | 2 |
| #8 | Edmonds Donna | 2 |
| #9 | Rachel Sorek | 1 |
| #10 | Anat Reiner-Benaim | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2019094219A1 | Diagnosis of autoimmune diseases | |
| WO2019064294A1 | Sle disease management | |
| US2018231565A1 | Methods for determining the risk of a systemic lupus erythematosus (sle) patient to develop neuropsychiatric syndromes | |
| CN107533058A | Use albumen, peptide and oligonucleotides diagnostic antigen systemic loupus erythematosus | |
| CN107533048A | For diagnosing the method and composition of brain damage or neurodegeneration |